HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER
Clinical trials for HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control early-spread prostate cancer
Disease control OngoingThis study looks at whether adding a precise type of radiation (SBRT) to intermittent hormone therapy can better control prostate cancer that has spread to a few places in the body. The trial involves 60 men whose cancer was detected by a special PET scan but not by standard scan…
Matched conditions: HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Double radiation attack: could a Drug-Radiation combo stop prostate cancer spread?
Disease control OngoingThis early-stage study tests whether combining a radioactive drug (177Lu-PSMA-617) with precise radiation therapy (SBRT) is safe for men with hormone-sensitive prostate cancer that has spread to a few other spots in the body. The drug seeks out and attacks cancer cells, while the…
Matched conditions: HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC